103 related articles for article (PubMed ID: 9796306)
1. [Pathophysiology of coronary spasm].
Kugiyama K; Yasue H
Nihon Rinsho; 1998 Oct; 56(10):2483-7. PubMed ID: 9796306
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina.
Kugiyama K; Ohgushi M; Motoyama T; Sugiyama S; Ogawa H; Yoshimura M; Inobe Y; Hirashima O; Kawano H; Soejima H; Yasue H
J Am Coll Cardiol; 1997 Oct; 30(4):920-6. PubMed ID: 9316519
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina.
Kugiyama K; Yasue H; Okumura K; Ogawa H; Fujimoto K; Nakao K; Yoshimura M; Motoyama T; Inobe Y; Kawano H
Circulation; 1996 Aug; 94(3):266-71. PubMed ID: 8759065
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers.
Kugiyama K; Yasue H; Ohgushi M; Motoyama T; Kawano H; Inobe Y; Hirashima O; Sugiyama S
J Am Coll Cardiol; 1996 Nov; 28(5):1161-7. PubMed ID: 8890810
[TBL] [Abstract][Full Text] [Related]
5. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina.
Egashira K; Katsuda Y; Mohri M; Kuga T; Tagawa T; Shimokawa H; Takeshita A
J Am Coll Cardiol; 1996 May; 27(6):1444-9. PubMed ID: 8626956
[TBL] [Abstract][Full Text] [Related]
6. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin.
Okumura K; Yasue H; Matsuyama K; Ogawa H; Kugiyama K; Ishizaka H; Sumida H; Fujii H; Matsunaga T; Tsunoda R
J Am Coll Cardiol; 1996 Jan; 27(1):45-52. PubMed ID: 8522709
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-mediated vasodilatation is decreased in forearm resistance vessels in patients with coronary spastic angina.
Moriyama Y; Tsunoda R; Harada M; Miyao Y; Yoshimura M; Kugiyama K; Ogawa H; Yasue H
Jpn Circ J; 2001 Feb; 65(2):81-6. PubMed ID: 11216830
[TBL] [Abstract][Full Text] [Related]
8. Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.
Barbato E; Piscione F; Bartunek J; Galasso G; Cirillo P; De Luca G; Iaccarino G; De Bruyne B; Chiariello M; Wijns W
Circulation; 2005 Jan; 111(3):288-94. PubMed ID: 15642763
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-dependent dilator response to substance P in patients with coronary spastic angina.
Okumura K; Yasue H; Ishizaka H; Ogawa H; Fujii H; Yoshimura M
J Am Coll Cardiol; 1992 Oct; 20(4):838-44. PubMed ID: 1382082
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.
Heitzer T; Rudolph V; Schwedhelm E; Karstens M; Sydow K; Ortak M; Tschentscher P; Meinertz T; Böger R; Baldus S
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1648-52. PubMed ID: 16675725
[TBL] [Abstract][Full Text] [Related]
11. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress.
Goto C; Higashi Y; Kimura M; Noma K; Hara K; Nakagawa K; Kawamura M; Chayama K; Yoshizumi M; Nara I
Circulation; 2003 Aug; 108(5):530-5. PubMed ID: 12874192
[TBL] [Abstract][Full Text] [Related]
12. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.
Fichtlscherer S; Dimmeler S; Breuer S; Busse R; Zeiher AM; Fleming I
Circulation; 2004 Jan; 109(2):178-83. PubMed ID: 14662709
[TBL] [Abstract][Full Text] [Related]
14. Increased basal tone and hyperresponsiveness to acetylcholine and ergonovine in spasm-related coronary arteries in patients with variant angina.
Lee SJ; Park SJ; Park SW; Kim JJ; Song JK; Hong MK; Kang DH; Cheong SS
Int J Cardiol; 1996 Jul; 55(2):117-26. PubMed ID: 8842780
[TBL] [Abstract][Full Text] [Related]
15. Exogenous hyaluronidase induces release of nitric oxide from the coronary endothelium.
Evora PR; Pearson PJ; Chua YL; Discigil B; Schaff HV
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):707-11. PubMed ID: 11003752
[TBL] [Abstract][Full Text] [Related]
16. The induction of nitric oxide-mediated relaxation of human isolated pulmonary arteries by PACAP.
Cardell LO; Hjert O; Uddman R
Br J Pharmacol; 1997 Mar; 120(6):1096-100. PubMed ID: 9134222
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus.
Heitzer T; Krohn K; Albers S; Meinertz T
Diabetologia; 2000 Nov; 43(11):1435-8. PubMed ID: 11126415
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction in human disease.
Drexler H; Hornig B
J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
[TBL] [Abstract][Full Text] [Related]
19. Vasomotility and nitric oxide bioactivity of the bridging segments of the left anterior descending coronary artery.
Shiode N; Kato M; Teragawa H; Yamada T; Hirao H; Nomura K; Sasaki N; Yamagata T; Matsuura H; Kajiyama G
Am J Cardiol; 1998 Feb; 81(3):341-3. PubMed ID: 9468080
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent relaxation by substance P in human isolated omental arteries and veins: relative contribution of prostanoids, nitric oxide and hyperpolarization.
Wallerstedt SM; Bodelsson M
Br J Pharmacol; 1997 Jan; 120(1):25-30. PubMed ID: 9117094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
